Importantly, it has been determined that applying RITA in combination with doxorubicin upon the pre-B ALL cells could promote chemosensitivity accompanied by p53-dependent and p53-independent apoptosis [721]. Here, TP53 is linked to acute lymphoblastic leukemia.